Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Facebook

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Feb 18, 2021 3:49pm

73 Views

Post# 32601321

RE:RE:RE:Facebook

Your right, Sheila took it over and tried to be like Kalyterian with the bassless Pumping and if you questioned her, You were booted, Just like the FSD Site and David Rosenberg.

Jmk2454 wrote:
Facebook page seemed to disappear over night. It wasn't bad when Tina was in charge - there was give and take - but Tina left and it changed.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida